BSX · News · 20261107N
Product Pipeline Progress
BOSTON SCIENTIFIC CORP · 2026-11-07 · Importance 40 · Surprise 42
Boston Scientific secured up to US$455 million from Blackstone Life Sciences to co-fund development of its VITALYST heart pump. The reported funding is directed toward development of the heart-pump product; the digest gives no development milestone, launch timing, or market-demand data.
Key facts
- Boston Scientific’s VITALYST heart pump is in development, with Blackstone Life Sciences co-funding its development. source